Abbott and MedImpact PBM cooperating in H. pylori eradication therapy.
Executive Summary
ABBOTT, MEDIMPACT PARTNERING ON H. PYLORI ERADICATION PROGRAM in an effort to get more managed care physicians and patients to use the combination therapy omeprazole (Astra Merck's Prilosec) and clarithromycin (Abbott's Biaxin) in the treatment of peptic ulcer disease. MedImpact VP-Disease State Management Robert Da Silva and Abbott National Managed Care Exec Vic Rosenshein discussed their partnership May 11 at the Academy of Managed Care Pharmacy's annual meeting in San Francisco.